QSOX1 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">QSOX1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>QSOX1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Quiescin Q6 Sulfhydryl Oxidase 1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>QSOX, Q6, QSCN6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q24.2</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Sulfhydryl oxidase, ERV/QUSOX family</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>QSOX1</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>603180</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/melanoma" style="color:#ef9a9a">Melanoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
Qsox1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...QSOX1 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">QSOX1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>QSOX1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Quiescin Q6 Sulfhydryl Oxidase 1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>QSOX, Q6, QSCN6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q24.2</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Sulfhydryl oxidase, ERV/QUSOX family</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>QSOX1</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>603180</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/melanoma" style="color:#ef9a9a">Melanoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
Qsox1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
QSOX1 (Quiescin Q6 Sulfhydryl Oxidase 1) is an enzyme-coding gene encoding a sulfhydryl oxidase that catalyzes the formation of disulfide bonds in proteins["@chakravarthi2006"][@sevier2008]. This ER-resident enzyme plays a critical role in protein folding, quality control, and the oxidative protein folding pathway["@hatahet2009"][@freedman1994]. QSOX1 has gained attention in neurodegenerative disease research due to its involvement in endoplasmic reticulum (ER) stress responses, protein aggregation, and oxidative stress — all key mechanisms in Alzheimer's disease (AD) and Parkinson's disease (PD)[@wang2016][@hotamisligil2010].
Gene Structure and Expression
The QSOX1 gene consists of multiple exons and encodes a protein of approximately 609 amino acids[@wells2008]. QSOX1 is widely expressed in various tissues, with high expression in the brain, particularly in [neurons](/entities/neurons) and glial cells[@thorpe2002]. It contains an N-terminal signal peptide for ER targeting, a thioredoxin domain, and a C-terminal sulfhydryl oxidase domain (ERO1-like)[@hoober1999].
Molecular Function
Catalytic Activity
QSOX1 catalyzes disulfide bond formation in newly synthesized proteins using molecular oxygen as the electron acceptor[@fass2013][@gross2002]:
Protein-SH + Protein-SH + O₂ → Protein-S-S-Protein + H₂O₂
This reaction is essential for:
- Proper protein folding in the ER
- Quality control in the secretory pathway
- Maturation of secreted and membrane proteins
Substrates
QSOX1 can oxidize various substrate proteins including[@appenzellerherzog2008]:
- Thioredoxin
- Protein disulfide isomerase (PDI)
- ERp44
- Various growth factors and cytokines
Cellular Localization
- Primary: Endoplasmic reticulum (ER) lumen
- Secondary: Golgi apparatus, secretory vesicles
- Extracellular: Detected in some bodily fluids
Role in Neurodegenerative Diseases
Alzheimer's Disease
QSOX1 plays multiple roles in AD pathogenesis[@hoober2019][@scheper2015]:
ER stress response: QSOX1 expression is upregulated during ER stress, a common feature in AD brains. The accumulation of misfolded [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau) proteins triggers the unfolded protein response (UPR)[@katayama2004].
Protein quality control: QSOX1 helps maintain proper disulfide bond formation in neuronal proteins. Dysfunction may contribute to protein aggregation[@kimata2011].
Oxidative stress: QSOX1 activity produces hydrogen peroxide as a byproduct. While the ER has antioxidant systems to handle this, excessive oxidative stress is a hallmark of AD[@butterfield2008].
Amyloid metabolism: Some studies suggest QSOX1 may interact with [amyloid precursor protein](/entities/app-protein) (APP) processing pathways[@obrien2011].
Synaptic function: Proper disulfide bond formation is essential for synaptic proteins, and QSOX1 dysfunction may affect synaptic plasticity[@hong2020].Parkinson's Disease
In Parkinson's disease, QSOX1 involvement includes[@ogawa2020][@lindholm2006]:
ER stress and [alpha-synuclein](/mechanisms/alpha-synuclein): QSOX1 helps manage ER stress induced by [alpha-synuclein](/proteins/alpha-synuclein) aggregation. QSOX1 upregulation has been observed in PD models[@kimata2020].
Mitochondrial function: There is crosstalk between ER stress and mitochondrial dysfunction in PD. QSOX1 may influence mitochondrial protein quality[@areagomez2019].
Dopaminergic neuron survival: The high metabolic demands of dopaminergic neurons make them particularly vulnerable to protein misfolding and ER stress[@bogaert2015].Other Neurodegenerative Diseases
- Amyotrophic Lateral Sclerosis (ALS): QSOX1 expression is altered in ALS models and may affect [TDP-43](/proteins/tdp-43) protein handling[@pasinelli2006].
- Huntington's Disease: QSOX1 may help manage mutant [huntingtin](/proteins/huntingtin-protein) protein aggregation[@takahashi2007].
- Prion Diseases: QSOX1 could play a role in prion protein quality control[@harris2019].
Therapeutic Implications
QSOX1 represents a potential therapeutic target for neurodegenerative diseases[@scalcon2020][@kim2008]:
QSOX1 modulators: Small molecules that enhance QSOX1 activity could improve protein folding capacity
Antioxidant approaches: Targeting downstream effects of QSOX1-mediated H₂O₂ production
ER stress modulators: Compounds that alleviate overall ER stress may be beneficialResearch Status
Preclinical studies are investigating QSOX1 modulators in cellular and animal models of neurodegeneration. No clinical trials for QSOX1-targeted therapies in neurodegenerative diseases have been initiated as of 2024.
Interactions and Pathways
Protein Interactions
- PDI (Protein Disulfide Isomerase): Key partner in ER protein folding
- ERp44: Involved in ER quality control
- ERdj3/5/8: Chaperone proteins in UPR signaling
- BiP/GRP78: Major ER chaperone
Pathway Involvement
- [Unfolded Protein Response](/entities/unfolded-protein-response) (UPR)
- ER-Associated Degradation (ERAD)
- Oxidative protein folding
- Protein disulfide isomerase pathway
- [Autophagy](/entities/autophagy)-lysosomal pathway
Background
The study of Qsox1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
Cross-References
- [QSOX1 Protein](/proteins/qsox1-protein)
- [Protein Quality Control](/mechanisms/protein-quality-control-network)mechanisms/protein-quality-control-network)
- [Unfolded Protein Response](/mechanisms/endoplasmic-reticulum-stress)mechanisms/er-stress-unfolded-protein-response)
- [ER Stress in Neurodegeneration](/mechanisms/er-stress-neurodegeneration)
- [Oxidative Stress in AD](/mechanisms/oxidative-stress-alzheimers)
- [Oxidative Stress in PD](/mechanisms/oxidative-stress-parkinsons)
- [Alpha-Synuclein Pathology](/mechanisms/alpha-synuclein-pathology)
- [Amyloid Cascade](/mechanisms/amyloid-cascade)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
- [ER-Associated Degradation](/mechanisms/erad-pathway)
External Links
- [NCBI Gene QSOX1](https://www.ncbi.nlm.nih.gov/gene/10286)
- [HGNC: QSOX1](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/15696)
- [UniProt: QSOX1](https://www.uniprot.org/uniprot/O00391)
- [OMIM: QSOX1](https://www.omim.org/entry/603180)
- [PharmGKB: QSOX1](https://www.pharmgkb.org/gene/PA134927)
References
[Chakravarthi S, Jessop CE, Bulleid NJ, The role of glutathione in disulphide bond formation and endoplasmic reticulum-oxidoreductin-1 (Ero1)-mediated oxidative protein folding (2006)](https://pubmed.ncbi.nlm.nih.gov/17052205/)
[Sevier CS, Kaiser CA, Ero1 and the role of disulfide bond formation in the endoplasmic reticulum (2008)](https://pubmed.ncbi.nlm.nih.gov/18850258/)
[Hatahet F, Ruddock LW, Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation (2009)](https://pubmed.ncbi.nlm.nih.gov/19450076/)
[Freedman RB, Hirst TR, Tuite MF, Protein disulphide isomerase: building bridges in protein folding (1994)](https://pubmed.ncbi.nlm.nih.gov/7940677/)
[Wang M, Kaufman RJ, The impact of protein-misfolding and ER stress on neurodegenerative diseases (2016)](https://pubmed.ncbi.nlm.nih.gov/27857110/)
[Hotamisligil GS, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20303879/)
[Wells M, Miao R, Wang J, et al, Structure and function of human QSOX1 (2008)](https://pubmed.ncbi.nlm.nih.gov/18775691/)
[Thorpe C, Hoober KL, Raje S, et al, Sulfhydryl oxidases: emerging catalysts of protein disulphide bond formation in eukaryotes (2002)](https://pubmed.ncbi.nlm.nih.gov/12061783/)
[Hoober KL, Thorpe C, A sulfhydryl oxidase from rat liver cytosol: purification and characterization (1999)](https://pubmed.ncbi.nlm.nih.gov/10074366/)
[Fass D, Sulfhydryl oxidases and the formation of disulfide bonds (2013)](https://pubmed.ncbi.nlm.nih.gov/23740172/)
[Gross E, Sevier CS, Vala A, et al, A new FAD-binding domain and the catalytic mechanism of Ero1 (2002)](https://pubmed.ncbi.nlm.nih.gov/11740505/)
[Appenzeller-Herzog C, Ellgaard L, The human Ero1-La and Ero1-Lb isoforms: differential roles in oxidative protein folding (2008)](https://pubmed.ncbi.nlm.nih.gov/17949261/)
[Hoober KL, Jonega R, Thorpe C, QSOX in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30582167/)
[Scheper W, Hoozemans JJ, The unfolded protein response in neurodegenerative diseases: a neuroprotective pathway? Trends Neurosci (2015)](https://pubmed.ncbi.nlm.nih.gov/26123373/)
[Katayama T, Imaizumi K, Manabe T, et al, Induction of neuronal apoptosis by ER stress (2004)](https://pubmed.ncbi.nlm.nih.gov/15048931/)
[Kimata Y, Kohno K, Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells (2011)](https://pubmed.ncbi.nlm.nih.gov/21071196/)
[Butterfield DA, Sultana R, Redox proteomics: understanding oxidative stress in Alzheimer disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18667175/)
[O'Brien RJ, Wong PC, Amyloid precursor protein processing and Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21456963/)
[Hong J, Luo Q, Xie Z, et al, Synaptic dysfunction in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/31884480/)
[Ogawa M, Fukui A, Uehara T, et al, QSOX1 and ER stress in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32898732/)
[Lindholm D, Wootz H, Korhonen L, ER stress and neurodegenerative diseases (2006)](https://pubmed.ncbi.nlm.nih.gov/16397578/)
[Kimata Y, Shirane A, Yoshida H, et al, ER stress and Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32293458/)
[Area-Gomez E, del Carmen Lara Castillo M, et al, UPRmt in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31054353/)
[Bogaert E, Van Damme P, Motor neuron disease: unraveling the role of ER stress (2015)](https://pubmed.ncbi.nlm.nih.gov/26203766/)
[Pasinelli P, Brown RH, Molecular biology of amyotrophic lateral sclerosis (2006)](https://pubmed.ncbi.nlm.nih.gov/16924260/)
[Takahashi Y, Okamoto Y, Popiel HA, et al, Heat shock protein 70 and ER stress in Huntington's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17212689/)
[Harris DA, Cellular biology of prion diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/30483949/)
[Scalcon V, Salerno G, Leonardi M, et al, Targeting ER stress response for neurodegenerative disease therapy (2020)](https://pubmed.ncbi.nlm.nih.gov/32073388/)
[Kim I, Xu W, Reed JC, Cell death and the unfolded protein response in disease (2008)](https://pubmed.ncbi.nlm.nih.gov/19043450/)Pathway Diagram
The following diagram shows the key molecular relationships involving QSOX1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)